Skip to main content

Table 1 Patient background data

From: Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series

Backgrounds

(n = 13)

Age, mean ± SD (range), years

63.7 ± 8.5 (50–86)

Male/Female, no

2/11

Weight, mean ± SD (range), kg

44.7 ± 6.1 (35–56)

Smoking history, no (%)

2 (15.4)

Medical history, no (%)

 

Mycobacterium avium complex pulmonary disease

5 (38.5)

 Pulmonary aspergillosis

2 (15.4)

 Hypertension

2 (15.4)

 Dyslipidemia

2 (15.4)

 Chronic obstructive pulmonary disease

1 (7.7)

Sarcoidosis

1 (7.7)

Chronic sinusitis

1 (7.7)

 Gastric cancer

1 (7.7)

 Breast cancer

1 (7.7)

Uterine myoma

1 (7.7)

Ovarian cyst

1 (7.7)